Press release
Macular Degeneration Treatment Market: Key Trends and Innovations Driving Growth
Macular Degeneration Treatment Market Size
The global macular degeneration treatment market is anticipated to expand from USD 16.79 billion in 2025 to USD 25.25 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 8.51%, according to a recent report by Mordor Intelligence. This growth is primarily attributed to the increasing prevalence of retinal disorders, an aging global population, and significant advancements in treatment options.
Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss among individuals aged 50 and older. The condition deteriorates the central portion of the retina, known as the macula, impairing central vision necessary for activities like reading and driving. As the global population ages, the incidence of AMD is expected to rise, thereby increasing the demand for effective treatment options.
Report Overview: https://www.mordorintelligence.com/industry-reports/macular-degeneration-treatment-market
Key Trends
Rising Prevalence of Retinal Disorders: The global burden of retinal diseases, including AMD and diabetic retinopathy, is escalating. A study published in the JAMA Network Journal in January 2024 projected that AMD would affect approximately 288 million individuals worldwide by 2040. Similarly, the prevalence of diabetic retinopathy is expected to reach 161 million by 2045. This increasing incidence underscores the urgent need for effective treatments.
Advancements in Treatment Modalities: Significant progress in therapeutic approaches, particularly in anti-vascular endothelial growth factor (anti-VEGF) therapies, has improved patient outcomes. For instance, in September 2024, Kyowa Kirin initiated a Phase-2 clinical trial to evaluate KHK4951, an experimental eye drop formulation of tivozanib, for wet AMD. Such innovations are expanding the arsenal of treatment options available to clinicians.
Increased Research and Development Investments: Pharmaceutical companies are investing heavily in R&D to develop novel therapies for macular degeneration. Collaborations, such as the partnership between Oculogenex and Forge Biologics in January 2023 to advance gene therapy programs for dry AMD, highlight the industry's commitment to addressing unmet medical needs.
Market Segmentation
The macular degeneration treatment market is segmented based on type, stage of disease, treatment type, route of administration, sales channel, and geography.
By Type:
Dry Age-related Macular Degeneration: Characterized by the thinning of the macula, leading to gradual vision loss.
Wet Age-related Macular Degeneration: Involves abnormal blood vessel growth under the retina, causing rapid vision deterioration.
By Stage of Disease:
Early-stage AMD: Presence of medium-sized drusen without significant vision loss.
Intermediate AMD: Larger drusen and possible pigment changes in the retina.
Late-stage AMD: Significant vision loss due to damage to the macula.
By Treatment Type:
Drugs: Includes anti-VEGF injections and other pharmacological agents.
Devices: Such as implantable miniature telescopes for advanced cases.
Surgery: Laser therapies and other surgical interventions.
By Route of Administration:
Intravenous Route: Systemic delivery of therapeutic agents.
Intravitreal Route: Direct injection into the vitreous humor of the eye.
By Sales Channel:
Ambulatory Surgical Centers: Facilities specializing in ocular surgeries.
Hospitals: Primary centers for diagnosis and treatment.
Other Sales Channels: Includes clinics and specialized eye care centers.
By Geography:
North America: Largest market share due to advanced healthcare infrastructure and high awareness levels.
Europe: Significant market presence with increasing adoption of novel therapies.
Asia-Pacific: Fastest-growing market, driven by a large aging population and improving healthcare facilities.
Middle East & Africa: Gradual market growth with rising healthcare investments.
South America: Emerging market with increasing focus on ophthalmic healthcare.
Get a Customized Report Tailored to Your Requirements - https://www.mordorintelligence.com/market-analysis/disease-specific-drugs
Key Players
Prominent players in the macular degeneration treatment market include:
Novartis AG: Offers treatments like Beovu (brolucizumab) for wet AMD.
Bausch Health Companies Inc.: Provides various ophthalmic products addressing retinal disorders.
REGENXBIO Inc.: Focuses on gene therapy approaches for retinal diseases.
F. Hoffmann-La Roche Ltd: Develops innovative therapies, including Vabysmo (faricimab) for retinal conditions.
Regeneron Pharmaceuticals Inc.: Known for Eylea (aflibercept), a leading anti-VEGF therapy for wet AMD.
These companies are actively engaged in research, product development, and strategic collaborations to enhance their market positions and address the growing demand for effective macular degeneration treatments.
Conclusion
The global macular degeneration treatment market is poised for substantial growth, driven by the increasing prevalence of retinal disorders, advancements in therapeutic options, and significant investments in research and development. As the aging population continues to expand, the demand for effective and innovative treatments for macular degeneration is expected to rise, presenting lucrative opportunities for market players to develop and introduce novel therapies.
Industry Related Reports
Skin Tears Treatment Market: The Global Skin Tears Treatment Market is categorized by Product Type (Moisture-Retentive Dressings, Barrier Films, Hyaluronic Acid Wound Devices, Gels and Creams, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography.
To know more visit this link: https://www.mordorintelligence.com/industry-reports/skin-tears-treatment-market
Tennis Elbow Treatment Market: The report highlights trends in the Elbow Stiffness Treatment Market, segmented by Treatment Type (Surgical Therapies, including Arthroscopic Surgery and Open Surgery, and Non-Surgical Therapies such as Extracorporeal Shock Wave Therapy, Braces, Medications, and Physical Therapies) and Geography (North America, Europe, Asia-Pacific, the Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/tennis-elbow-treatment-market
Hepatitis B Treatment Market: The report explores trends in the Hepatitis B Treatment Market, segmented by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, and Other Types), Drug Class (Interferon, Monoclonal Antibodies, Non-Structural Protein 5A (NS5A) Inhibitors, Nucleotide Analog Reverse Transcriptase Inhibitors, Nucleotide Analog NS5B Polymerase Inhibitors, Multi-Class Combination Therapies, and Others), and Geography (North America, Europe, Asia-Pacific, the Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/hepatitis-therapeutics-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Macular Degeneration Treatment Market: Key Trends and Innovations Driving Growth here
News-ID: 3822408 • Views: …
More Releases from Mordor Intelligence
Automotive Lubricants Market to Grow from 23.23 Billion Liters in 2025 to 28.01 …
Automotive Lubricants Market Overview:
Global Automotive Lubricants Market is set to climb steadily from 23.23 billion liters in 2025 to 28.01 billion liters by 2030, reflecting a compound annual growth rate (CAGR) of 3.81%. The market's expansion is supported by mature vehicle fleets in developed regions, growing demand in emerging markets, and a shift toward higher-quality synthetic lubricants that contribute to better engine performance and longer intervals between oil changes. Asia‐Pacific…
Antimicrobial Textile Market to Grow from USD 13.77 Billion in 2025 to USD 16.55 …
Antimicrobial Textile Market is projected to rise from USD 13.77 billion in 2025 to reach USD 16.55 billion by 2030, representing a steady 3.75% CAGR. This growth reflects both sustained demand from healthcare facilities aiming to limit infection spread and the expanding use of antimicrobial fabrics in sportswear, home goods, and public spaces. The market is entering a mid‐maturity phase, shaped by increased hygiene awareness and evolving rules on antimicrobial…
Platinum Market Size to Reach USD 10.45 Billion by 2030 Driven by Automotive, Je …
Platinum Market is projected to grow from USD 8.51 Billion in 2025 to USD 10.61 Billion by 2030, registering a CAGR of 4.52% during the forecast period. This growth is attributed to rising demand in automotive catalytic converters, expanding adoption in hydrogen fuel cell technologies, and steady consumption in the jewelry sector across key markets like China and India. Additionally, platinum's increasing use in chemical processing, electronics, and recycling initiatives…
Silicone Market to Reach 4.08 Million Tons by 2030, Driven by Construction, Indu …
Introduction to the Silicone Market Outlook
Silicone Market forecast anticipates growth from an estimated 3.17 million tons in 2025 to 4.08 million tons by 2030, representing a solid CAGR of 5.19% over the period. Covering the historical span from 2019 to 2024 and projections through 2030, this data provides a comprehensive view of the silicone demand trajectory
Silicones are widely used in applications like sealants, coatings, elastomers, adhesives, and more. Demand is…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
